Congenital hyperinsulinism as the presenting feature of Kabuki syndrome: clinical and molecular characterization of 9 affected individuals
Yap Kl(University of Chicago), Del Gaudio D(University of Chicago), Priscilla Kandikatla(University of Chicago), A Devarajan(Boston Children's Hospital), Declan Cody(Children's Health Ireland at Crumlin), Daniel L. Fischer(University of Chicago), Burrage LC(Baylor College of Medicine), Amilcar Diaz(Miami Children's Hospital), Greeley SAW, Viswateja Nelakuditi(University of Chicago), Darrel Waggoner(University of Chicago), Lewis Am(Boston Children's Hospital), Pratik Shah, Edmondson AC(University of Chicago), Jeha GS(Texas Children's Hospital), Lisa Truong(Oregon State University), Patrick Thornton(Beaumont Hospital), Jacea Deml(University of Chicago), Olaf A. Bodamer(Broad Institute), Sian Ellard(University of Exeter), Sara Halbach(University of Chicago), Das S(University of Chicago), Johnson AEK, De León(Children's Hospital of Philadelphia), Benavides VC(University of Illinois Urbana-Champaign)
Cited by 6
Related Papers
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
|New England Journal of Medicine|2014|1.6k
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
|New England Journal of Medicine|2019|823
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy
|European Journal of Pediatrics|2007|535
The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes
|Diabetologia|2012|337
Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism–dystonia
|Nature Communications|2016|326